Key facts
- It has raised $1.3M; the latest was Angel (individual) ($750K) in Oct 2024.
- Notable investors include Invest Nebraska, MOVE Venture Capital, Nelnet Ventures, The Combine (Nebraska).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for MTE Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for MTE Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MTE Biotech
Developer of a molecular trait technology designed to produce enzymes and chemicals from agricultural and municipal waste. The company's tech thrives at the limits of life under conditions that mimic biofuel processing, generate biofuels and renewable chemicals from agricultural waste, turning low-value starting materials into high-value renewable resources without competing with food or feed, enabling users to increase their product yields and growth profit margin.
- Sector
- Healthcare
- HQ
- Lincoln, NE, United States
- Founded
- 2016
- Employees
- 2
- Website
- mtebiotech.com/
- Ownership
- Privately Held (backing)
MTE Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MTE Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MTE Biotech in its N-PORT filings yet. We sweep new filings monthly.